The Impact of Vaccination Among Hospitalized Patients with the Diagnosis of COVID-19
Authors:
- Yesim YildizYYYesim Yildiz
- Hasan Selcuk OzgerHOHasan Selcuk Ozger
- Ali AcarAAAli Acar
- Aysegul Seremet-KeskinASAysegul Seremet-Keskin
- Umut Devrim BinayUBUmut Devrim Binay
- Gulten UnluGUGulten Unlu
- Halim BayramHBHalim Bayram
- Ali AslanAAAli Aslan
- Mustafa Ozgur AkcaMAMustafa Ozgur Akca
- Dilek KaramanliogluDKDilek Karamanlioglu
- Osman InanOIOsman Inan
- Safak KayaSKSafak Kaya
Open Access
- 23 June 2023
- journal article
- research article
- Published by Doc Design and Informatics Co. Ltd. in Infectious Diseases and Clinical Microbiology
- Vol. 5 (2) , 118-126
Abstract
Objective: We aimed to investigate the vaccination status and the risk factors for the intensive care unit (ICU) support need of the laboratory-confirmed breakthrough COVID-19 infection inpatients. Materials and Methods: This multi-center point-prevalence study was conducted on inpatients, divided into two groups as ‘fully’ and ‘partially’ vaccinated according to COVID-19 vaccination status. Results: Totally 516 patients were included in the study. The median age was 65 (55-77), and 53.5% (n=276) of the patients were male. Hypertension (41.9%, n=216), diabetes mellitus (DM) (31.8%, n=164), and coronary artery disease (CAD) (16.3%, n=84) were the predominant comorbidities. Patients were divided into two groups ICU (n=196) and non-ICU (n=301). Hypertension (p=0.026), DM (p=0.048), and congestive heart failure (CHF) (p=0.005) were significantly higher in ICU patients and the median age was younger among non-ICU patients (p=0.033). Of patients, 16.9% (n=87) were fully vaccinated, and this group’s need for ICU support was statistically significantly lower (p=0.021). Conclusion: We conclude that older age, hypertension, DM, CHF, and being partially vaccinated were associated with the need for ICU support. Therefore, all countries should continuously monitor post-vaccination breakthrough COVID-19 infections to determine the national booster vaccine administration approach that will provide vulnerable individuals the highest protection. Keywords: COVID-19 vaccine, intensive care unit, risk factor, SARS-CoV-2 infection, vaccine breakthrough infections, variant of concernsKeywords
This publication has 18 references indexed in Scilit:
- A systematic review of Vaccine Breakthrough Infections by SARS-CoV-2 Delta VariantInternational Journal of Biological Sciences, 2022
- Immunogenicity and safety of a third dose of CoronaVac, and immune persistence of a two-dose schedule, in healthy adults: interim results from two single-centre, double-blind, randomised, placebo-controlled phase 2 clinical trialsThe Lancet Infectious Diseases, 2021
- BNT162b2 vaccine breakthrough: clinical characteristics of 152 fully vaccinated hospitalized COVID-19 patients in IsraelClinical Microbiology and Infection, 2021
- Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care SettingsNew England Journal of Medicine, 2021
- New COVID-19 Cases and Hospitalizations Among Adults, by Vaccination Status — New York, May 3–July 25, 2021MMWR. Morbidity and Mortality Weekly Report, 2021
- Covid-19: How many variants are there, and what do we know about them?: Video 1BMJ, 2021
- Vaccination status and COVID-19 related mortality: A hospital based cross sectional studyMedical Journal Armed Forces India, 2021
- Vaccine Breakthrough Infections with SARS-CoV-2 VariantsNew England Journal of Medicine, 2021
- Efficacy and Safety of COVID-19 Vaccines in Phase III Trials: A Meta-AnalysisVaccines, 2021
- Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infectionNature Medicine, 2021